Skip to content

Treatment strategies of colorectal liver metastases

Treatment strategies of colorectal liver metastases - Treatment strategies of colorectal liver metastases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000059404
Enrollment
130
Registered
2025-10-15
Start date
2024-09-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

None listed

Sponsors

Shimane University Faculty of Medicine.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Individuals diagnosed with colorectal cancer liver metastases via imaging studies (Dynamic CT and MRI examinations) between January 2017 and June 2024. 2) No restrictions on age or gender. 3) No restrictions on the number of liver metastases. 4) Eastern Cooperative Oncology Group Performance Status (ECOG-PS) < 2. 5) Child-Pugh score: 5 to 9 (Grade A~B).

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Overall survival

Secondary

MeasureTime frame
Incidence rate of adverse events (adverse reactions)

Countries

Japan

Contacts

Public ContactTakahito Taniura

Shimane University Faculty of Medicine. Department of Digestive and General Surgery

taniura@med.shimane-u.ac.jp0853202232

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026